The information on this site is not intended for consumers. The information is directed exclusively to healthcare professionals and practitioners.
Discover Dexcom Continuous Glucose Monitoring (CGM) Systems
Dexcom; Global leaders in glucose health1
For over 25 years, Dexcom has continuously innovated in developing accurate and reliable CGM systems, empowering people living with diabetes to make informed decisions and improve their overall health outcomes.2-6
Easy. Accurate.* Better health outcomes.2-6
Easy for you and your patients
- Patient self setup instructions in the app
- No fingerpricks or calibrations needed†
- 30 minute warm up sensor time - the fastest of any CGM on the market‡
† If glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Superior Accuracy*
- Dexcom G7 and Dexcom ONE+ are accurate and precise across all days of wear, rates of change, glucose levels (2.2 to 22.2 mmol/L) and ages (2+).7,8
Better health outcomes2-6
- Dexcom is the most researched CGM with over 250 registered clinical trials.§,9
- #1 clinically proven CGM||
- Dexcom CGM is shown to benefit people living with diabetes through real world clinical outcomes.¶,10,11
Our CGM portfolio enables confident diabetes management
An advanced CGM with insulin pump connectivity and predictive alerts
- For people living with type 1 diabetes
- Insulin pump connectivity: including the t:slim X2 insulin pump
- NDSS subsidy available for people living with Type 1 diabetes^
- Funding available for eligible DVA clients
Smart device sold separately.#
An easy CGM with essential alerts for people living with type 2 diabetes
- For people living with type 2 diabetes and suitable for gestational diabetes
- Insulin pump connectivity not supported
- Available on our online shop
- Funding available for eligible DVA clients
Smart device sold separately.#
AMSL Diabetes Education Hub
Continue your education journey by signing up to AMSL Diabetes Education Hub and gain access to:
- On-demand product training modules
- Expert-led educational videos and webinars
- Brochures, guides and resources
Complete our interactive learning modules to earn a certificate!
Dexcom Clarity puts your patient’s care in one place
Dexcom Clarity simplifies access to patient glucose data, helping you identify relevant glucose patterns, insights and trends to support better-informed diabetes management decisions.
Easy-to-use clinic portal
Your patients’ continuous glucose data is accessible via an easy-to-use online clinic portal, supporting a more simplified workflow.
Simple and clear insights
Interactive reports are automatically accessible, supporting personalised interactions with patients and maximising the value of each appointment.
We're here to support you
Speak to a representative today!
Have questions?
Fill out the contact form and one of our Dexcom representatives will be in touch with you soon.
Fill out the contact form and one of our Dexcom representatives will be in touch with you soon.
Request a trial kit!
Invite your patients to trial Dexcom CGM, complete with a starter kit and follow-up from our team to support a confident start.
*As compared to G6
† If glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions
‡ Dexcom G7 and One+ can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer
§ Based on comparison of completed trials registered at clinicaltrials.gov as of March 2025
|| Dexcom CGM systems have been studied in over 70 registered interventional clinical trials [clinicaltrials.gov]. Dexcom’s internal data on file, 2024. A copy of this data is available upon request.
¶ Dexcom CGMs are continuous glucose monitoring systems indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self monitoring of blood glucose (SMBG) is indicated
#Display devices sold separately. For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
^ Eligibility criteria applies. Visit ndss.com.au/cgm for more details
** Internet connection required to send data to Dexcom Clarity
†† Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity.
† If glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions
‡ Dexcom G7 and One+ can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer
§ Based on comparison of completed trials registered at clinicaltrials.gov as of March 2025
|| Dexcom CGM systems have been studied in over 70 registered interventional clinical trials [clinicaltrials.gov]. Dexcom’s internal data on file, 2024. A copy of this data is available upon request.
¶ Dexcom CGMs are continuous glucose monitoring systems indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self monitoring of blood glucose (SMBG) is indicated
#Display devices sold separately. For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
^ Eligibility criteria applies. Visit ndss.com.au/cgm for more details
** Internet connection required to send data to Dexcom Clarity
†† Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity.
References: 1. Seagrove Diabetes Bluebook 2024. 2. Beck RW, et al. JAMA. 2017;317(4):371-378. 3. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4. Martens T, et al. JAMA. 2021;325(22):2262-2272. 5. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 6. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 7. Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-80. 8. Laffel LM et al. J Diabetes Sci Technol. 2023 Jul; 17(4): 962–967. 9. clinicaltrials.gov. 10. Karter AJ, et al. JAMA. 2021;325(22):2273-84. 11. Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39.